Literature DB >> 31983094

Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375.

Nan Xu1, Lixing Qiao, Liping Yin, Han Li.   

Abstract

PURPOSE: The vital role of long noncoding RNAs (lncRNAs) in tumor progression have been identified in numerous studies. In this research, lncRNA ROR1-AS1 was explored to verify its function during the development of lung adenocarcinoma (LAC).
METHODS: Real-time quantitative polymerase chain reaction (RT-qPCR) was utilized to measure ROR1-AS1 expression of LAC tissues. Function assays including wound healing assay and transwell assay were conducted to detect the effect of knockdown of ROR1-AS1 on the metastasis of LAC, and luciferase assays and RNA immunoprecipitation assay (RIP) were also performed to explore the underlying mechanism.
RESULTS: ROR1-AS1 expression level was significantly higher in LAC samples compared with that in adjacent tissues, which was associated with patients' prognosis. Knockdown of ROR1-AS1 inhibited cell migration and cell invasion of LAC cells via suppressing epithelial-mesenchymal transition (EMT) process. Furthermore, it was discovered that ROR1-AS1 acted as a competing endogenous RNA via sponging miR-375 in LAC.
CONCLUSIONS: These results suggested that ROR1-AS1 could act as a sponge for miR-375 and promo//e cell migration and invasion through suppressing the process of EMT in LAC, which may offer a potential therapeutic target in LAC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31983094

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

1.  Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Guohong Huang; Yimei Yang; Mengxin Lv; Tian Huang; Xiaoyan Zhan; Wei Kang; Jianghou Hou
Journal:  Onco Targets Ther       Date:  2020-09-30       Impact factor: 4.147

2.  MCM3AP-AS1 promotes cisplatin resistance in gastric cancer cells via the miR-138/FOXC1 axis.

Authors:  Han Sun; Ping Wu; Bao Zhang; Xia Wu; Weixu Chen
Journal:  Oncol Lett       Date:  2021-01-18       Impact factor: 2.967

Review 3.  MicroRNA-375: potential cancer suppressor and therapeutic drug.

Authors:  Jiahui Wei; Yiran Lu; Ruiqing Wang; Xiangzhu Xu; Qing Liu; Song He; Huihao Pan; Xinmiao Liu; Bao Yuan; Yu Ding; Jiabao Zhang
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

4.  Long Noncoding RNA NR2F1-AS1 Enhances the Migration and Invasion of Hepatocellular Carcinoma via Modulating miR-642a/DEK Pathway.

Authors:  Yingxia Xu; Chunrong Han; Jing Sun; Jingjing Zhao; Qing Liu; Ping An
Journal:  J Oncol       Date:  2021-09-21       Impact factor: 4.375

5.  MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.

Authors:  Veronika Petkova; Dora Marinova; Silva Kyurkchiyan; Gergana Stancheva; Evgeni Mekov; Darina Kachakova-Yordanova; Yanina Slavova; Dimitar Kostadinov; Vanyo Mitev; Radka Kaneva
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.